A study published Online First by The Lancet has found that patients with advanced Hodgkin's lymphoma (a cancer affecting lymph tissue) can be treated more effectively with lower doses of chemotherapy. The study is by Dr ...
Apr 3, 2012
0
0
The use of ultrasound-guided surgery to remove tumours from women who have palpable breast cancer is much more successful than standard surgery in excising all the cancerous tissue while sparing as much healthy tissue as ...
Mar 23, 2012
0
0
Surgery for obesity improves lives and may save money. There are two very commonly performed operations to treat morbid obesity in the UK but it is unclear which is the most effective and provides the greatest benefit for ...
Feb 27, 2012
0
0
Hot flushes and night sweats (HFNS) affect 65-85% of women after breast cancer treatment; they are distressing, causing sleep problems and decreased quality of life. Hormone replacement therapy is often either undesirable ...
Feb 14, 2012
0
0
(Medical Xpress) -- Bowel screening reduces the number of deaths from bowel cancer in Scotland by more than 25 per cent, according to research* presented at the National Cancer Research Institute (NCRI) Cancer Conference ...
Nov 9, 2011
0
0
The third paper in The Lancet Series on Global Mental Health examines mental health and psychosocial support (MHPSS) in humanitarian settings, and points out that most research and evidence is focused on interventions that ...
Oct 16, 2011
0
0
An updated study published in this week's PLoS Medicine gives some new information on the cardiovascular risks of non-steroidal anti-inflammatory drugs (NSAIDs) and suggests that among these commonly used drugs, naproxen ...
Sep 27, 2011
0
0
The first randomised trial to investigate the use of trastuzumab emtansine (T-DM1) – an antibody-guided drug – for the initial treatment of HER2- (human epidermal growth factor receptor-2) positive metastatic breast ...
Sep 25, 2011
0
0
Melanoma of the eye (ocular or uveal melanoma) frequently spreads to the liver and, once this has happened, there is no effective treatment and patients die within an average of two to four months. Only about one in ten patients ...
Sep 23, 2011
0
0
The second generation drug-eluting stent Xience V performs well in patients having primary PCI for ST elevation myocardial infarction, and has a better safety profile than that of bare metal stents, according to results of ...
Aug 30, 2011
0
0
